September 1, 2019
Briefings on APCs

Perhaps the most momentous Quality Payment Program (QPP) news in the proposed 2020 Medicare physician fee schedule is the Pathways (MVP) version of the Merit-based Incentive Payment System (MIPS) — but that’s not happening until 2021.

September 18, 2019
HIM Briefings

As Medicare Advantage makes strides to becoming the new norm, organizations need to establish new processes, educate staff, and advocate for patients. Learn how your organization can keep pace with change before it’s too late to catch up.

September 4, 2019
HIM Briefings

The 2020 IPPS final rule made major changes to the hospital wage index and new technology payments. Brush up on the details to ensure your organization is ready.

August 30, 2019
News & Insights

The Revenue Integrity Symposium is a conference that truly speaks to the contemporary and emerging issues that revenue integrity professionals grapple with.

August 28, 2019
News & Insights

The Office of Inspector General (OIG) will review Medicare’s diagnosis-related group (DRG) window policy to determine whether the program could save money by expanding the policy to include more days, according to an update to the OIG Work Plan.

August 26, 2019
News & Insights

Q: How do we bill for items provided to a patient participating in a clinical trial that are not listed on the billing intention?

August 26, 2019
News & Insights

CMS could have saved its beneficiaries an additional $2.9 million in 2017 had it implemented a more expansive price substitution policy for Part B drugs, according to an Office of Inspector General (OIG) report. 

August 19, 2019
News & Insights

Findings from a Comprehensive Error Rate Testing (CERT) study show that insufficient documentation caused most improper payments for chiropractic services billed to Medicare in 2018, according to the July 2019 Medicare Quarterly Compliance Newsletter.

August 19, 2019
News & Insights

Q: How can we ensure key staff are kept up to date on commercial payer changes?

August 14, 2019
News & Insights

Chimeric antigen receptor T-cell (CAR-T) therapy will be covered for Medicare beneficiaries nationally, according to an August 7 CMS press release.

Pages